Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05657145 · ClinicalTrials.gov registry record
Visualization of the Papilla Through Use of the NuView Device in Patients With FAP
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 3
- Enrollment target
NCT05657145: Completed study, sponsored by Vanderbilt University Medical Center.
NCT05657145 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05657145 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The goal of this observational study is to test the NuView device in participants with familial adenomatous polyposis (FAP). The main question it aims to answer is: * can the papilla be visualized using a forward-facing endoscope outfitted with the NuView device. Participants will undergo standard of care esophagogastroduodenoscopy with an additional endoscopic exam using NuView device, for which participant have given prior consent.
Primary Outcome
Successful visualization of the papilla with a standard gastroscope equipped with the NuView platform.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2023-01-27 |
| Est. Completion | 2025-12-30 |
What the finished NCT05657145 record still lists
NCT05657145 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05657145 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05657145 about?
NCT05657145 is a clinical study titled "Visualization of the Papilla Through Use of the NuView Device in Patients With FAP". The goal of this observational study is to test the NuView device in participants with familial adenomatous polyposis (FAP). The main question it aims to answer is: * can the papilla be visualized using a forward-facing endoscope outfitted with the NuView device. Participants will undergo standard ...
What is the current status of trial NCT05657145?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2023-01-27. Estimated completion is 2025-12-30.
Who is sponsoring clinical trial NCT05657145?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI